Letter: B-lymphocytes as target cells for E.B. virus transformation

Mizuno, F; Aya, T; Osato, T
September 1974
British Medical Journal;9/14/1974, Vol. 3 Issue 5932, p689
Academic Journal
No abstract available.


Related Articles

  • Cultured "hairy cells" infected with Epstein-Barr virus: evidence for B-lymphocyte origin. Lemon, Stanley M.; Pagano, Joseph S.; Utsinger, Peter D.; Sinkovics, Joseph G.; Lemon, S M; Pagano, J S; Utsinger, P D; Sinkovics, J G // Annals of Internal Medicine;Jan79, Vol. 90 Issue 1, p54 

    Discusses evidence for B-lymphocyte origin in cultured hairy cells infected with Epstein-Barr virus (EBV). Characteristics of cultured hairy cells; Analysis which confirmed the presence of EBV DNA in the cell line.

  • Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors. Taher, T. E.; Tulone, C.; Fatah, R.; D'Acquisto, F.; Gould, D. J.; Mageed, R. A. // Gene Therapy;Jul2008, Vol. 15 Issue 13, p998 

    B-lymphocytes play a key role in the pathogenesis of many immune-mediated diseases, such as autoimmune and atopic diseases. Therefore, targeting B-lymphocytes provides a rationale for refining strategies to treat such diseases for long-term clinical benefits and minimal side effects. In this...

  • "SPONTANEOUS" CYTOLYSIS BY NORMAL HUMAN LYMPHOCYTES OF BURKITT'S LYMPHOMA CELLS OF THE EB2 CELL LINE. Matthews, N.; MacLaurin, B.P. // Australian Journal of Experimental Biology & Medical Science;Aug1974, Vol. 52 Issue 4, p655 

    Discusses the relationship between spontaneous cytolysis by normal human lymphocytes of Burkitt's lymphoma cells of the EB2 cell line and sensitization of EB virus. Presence of specific anti-EB2 serum; Antibody-induced lymphocyte-mediated cytotoxicity.

  • EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1. Lu, Fang; Chen, Horng-Shen; Kossenkov, Andrew V.; DeWispeleare, Karen; Won, Kyoung-Jae; Lieberman, Paul M. // PLoS Pathogens;1/11/2016, Vol. 12 Issue 1, p1 

    Epstein-Barr Virus (EBV) transforms resting B-lymphocytes into proliferating lymphoblasts to establish latent infections that can give rise to malignancies. We show here that EBV-encoded transcriptional regulator EBNA2 drives the cooperative and combinatorial genome-wide binding of two master...

  • Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase. Kashuba, Elena; Kashuba, Vladimir; Sandalova, Tatjana; Klein, George; Szekely, Laszlo // BMC Cell Biology;2002, Vol. 3, p23 

    Background: Epstein-Barr virus (EBV) infects resting B-lymphocytes and transforms them into immortal proliferating lymphoblastoid cell lines (LCLs) in vitro. The transformed immunoblasts may grow up as immunoblastic lymphomas in immuno-suppressed hosts. Results: In order to identify cellular...

  • The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8 Banerjee, Shuvomoy; Lu, Jie; Cai, Qiliang; Saha, Abhik; Jha, Hem Chandra; Dzeng, Richard Kuo; Robertson, Erle S. // PLoS Pathogens;May2013, Vol. 9 Issue 5, p1 

    Epstein-Barr virus (EBV) is linked to a broad spectrum of B-cell malignancies. EBV nuclear antigen 3C (EBNA3C) is an encoded latent antigen required for growth transformation of primary human B-lymphocytes. Interferon regulatory factor 4 (IRF4) and 8 (IRF8) are transcription factors of the IRF...

  • A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog. Bernhardt, Katharina; Haar, Janina; Tsai, Ming-Han; Poirey, Remy; Feederle, Regina; Delecluse, Henri-Jacques // PLoS Pathogens;1/22/2016, Vol. 12 Issue 1, p1 

    The Epstein-Barr virus (EBV) infects and transforms B-lymphocytes with high efficiency. This process requires expression of the viral latent proteins and of the 3 miR-BHRF1 microRNAs. Here we show that B-cells infected by a virus that lacks these non-coding RNAs (Δ123) grew more slowly...

  • Vaccination against EB virus.  // British Medical Journal;12/18/1976, Vol. 2 Issue 6050, p1467 

    Examines the efficacy of vaccination against Epstein-Barr (EB) virus. Association of EB virus infections with Burkitt's lymphoma and nasopharyngeal carcinoma; Evidence that EB virus causes cancer in man; Consequences of vaccination against EB virus.

  • Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: A molecular link to cancer metastasis. Subramanian, Chitra; Cotter, Murray A.; Robertson, Erle S. // Nature Medicine;Mar2001, Vol. 7 Issue 3, p350 

    Epstein-Barr virus (EBV) is an oncogenic virus associated with a number of human malignancies including Burkitt lymphoma, nasopharyngeal carcinoma, lymphoproliferative disease and, though still debated, breast carcinoma. A subset of latent EBV antigens is required for mediating immortalization...

  • Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Brennan, Paul; Mehl, Anja M.; Jones, Matthew; Rowe, Martin // Oncogene;2/14/2002, Vol. 21 Issue 8, p1263 

    Presents a study that examined the role of the signaling molecule phosphatidylinositol 3-kinase in the regulation of growth and survival of immortalized B-lymphocytes. Factors that contribute to the development of lymphoma; Features of B-cell transformation; Elements of B-cell malignancies;...


Read the Article

Other Topics